SYRE Dividend History & Analysis | N/A Yield
SYRE has a dividend yield of N/A and paid N/A per share in the last 12M. Complete payout history, full analyses and peer comparison.
Top Dividend Payers in Biotechnology
| Symbol | Market Cap USD | Dividend Yield TTM | Yield on Cost 5y |
|---|---|---|---|
| ABBV | 387,093 M | 3.34% | 7.54% |
| AMGN | 198,244 M | 3.21% | 5.93% |
| GILD | 176,133 M | 2.79% | 5.63% |
| HLN | 46,623 M | 1.76% | 2.46% |
| BIM | 13,627 M | 0.74% | 0.75% |
| Symbol | Market Cap USD | Growth Rate | Consistency |
|---|---|---|---|
| BTX | 1,425 M | 134% | 95.6% |
| HLN | 46,623 M | 30.1% | 100% |
| AMGN | 198,244 M | 7.84% | 100% |
| BIM | 13,627 M | 9.76% | 96.0% |
| ABBV | 387,093 M | 5.98% | 100% |
Quality Dividend Peers in Biotechnology
3.21% Yield
2.79% Yield
SYRE Dividend History: as of February 2026
No dividends paid yet.SYRE Dividend FAQ
Spyre Therapeutics, Inc. (NASDAQ: SYRE) is a clinical-stage biotech focused on inflammatory bowel disease (IBD). Its lead candidate, SPY001, is a human IgG1 monoclonal antibody that selectively blocks the α4β7 integrin, a proven target in ulcerative colitis and Crohn’s disease. The pipeline also includes SPY002 (anti-TL1A), SPY120 (a SPY001 + SPY002 combo), and early-stage programs targeting IL-23 (SPY003) and various antibody combinations (SPY004, SPY130, SPY230). The company, formerly Aeglea BioTherapeutics, rebranded in November 2023 and is headquartered in Waltham, Massachusetts.
What is the Dividend Yield of SYRE?
As of February 2026, SYRE`s dividend yield is %. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - by the current share price of 35.12.Does SYRE pay a dividend?
As of February 2026 SYRE does not pay a dividend.How often does SYRE pay dividends?
Over the last 12 months, SYRE has issued dividend payments.SYRE dividend forecast
Based on historical data, the forecasted dividends per share for SYRE for the next 4 payments are between 0 (+0.0%) and 0 (+0.0%).This suggests the dividend will remain relatively stable.
Will SYRE pay dividends in 2026?
The next Ex-Dividend date for Spyre Therapeutics (SYRE) is currently unknown.What is the next Ex-Dividend Date for SYRE?
The next Ex-Dividend date for Spyre Therapeutics (SYRE) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.What is the Dividend Growth of SYRE?
SYRE's average dividend growth rate over the past 5 years is -% per year.
What is the Yield on Cost of SYRE?
SYRE's 5-Year Yield on Cost is -%. If you bought SYRE's shares at 192.75 five years ago, your current annual dividend income (- per share, trailing 12 months) equals -% of your original purchase price.What is the Payout Consistency of SYRE?
SYRE Payout Consistency is 0.0%.
The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number.
Does SYRE have a good Dividend Yield?
SYRE`s % Dividend Yield is considered as unknown.What is the Dividend Payout Ratio of SYRE?
The Dividend Payout Ratio of SYRE is unknown.What is the Dividend Rating of SYRE?
SYRE`s Overall Dividend Rating is (unknown). Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.Key Metric Definitions
- Dividend Yield
- Annual dividend per share divided by current share price.
- Payout Ratio
- Percentage of earnings paid as dividends. Below 60% = safe, above 100% = unsustainable.
- Payout FCF
- Percentage of Free Cash Flow paid as dividends. More reliable than Payout Ratio since it measures actual cash.
- Growth Rate (CAGR)
- Compound annual growth rate of dividends over the last 5 years.
- Consistency
- Reliability of dividend payments over lifetime. Penalizes cuts and pauses.
- Yield on Cost
- Your effective yield if you bought 5 years ago. Shows dividend growth impact over time.
- Streak
- Consecutive years of dividend payments. 25+ years = Dividend Aristocrat.
- Dividend Rating
- Proprietary score (0-100) combining yield, growth, safety and consistency.
Last update: 2026-02-01 02:19